TTD Drug ID: DAP001062

Drug Information
Name	Olopatadine
Synonyms	Dibenz(b,e)oxepin-2-acetic acid, 11-(3-dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; Allelock; Patanol; SMR000469220; Pataday; AC1NR00D; MolPort-003-986-254; CID5281071; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid, hydrochloride; OLOPATADINE HCl; MLS001401465; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid hydrochloride; ALO4943A; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid; L000748; CHEMBL1719; O0361; SAM001246802; AL-4943A; Olopatadine [INN:BAN]; Olopatadine; KW-4943A; 140462-76-6; CID5282402; DB00768; {(11Z)-11-[3-(dimethylamino)propylidene]-6,11-dihydrodibenzo[b,e]oxepin-2-yl}acetic acid; TL8000403; AC1NQXZH; KW 4679; LS-61598; 11-(3-(dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; S2494_Selleck; 113806-05-6; LS-172239; STK624184; Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-; Opatanol; 11-((Z)-3-(Dimethylamino)propylidene)-6,11-dihydrodibenz(b,e)oxepin-2-acetic acid; Patanase; ALO-4943A; 2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid hydrochloride; 113806-05-6 (Parent); KW-4679; CPD000469220; OLOPATADINE HYDROCHLORIDE; UNII-2XG66W44KF; 140462-76-6 (hydrochloride); TL8000904; MolPort-003-986-408; FT-0082377; BIDD:GT0285; HMS2089K10; Bio-0072; UNII-D27V6190PM; HCl of KW 4679; SBB066095
Trade Name	Pataday; Patanol S; Patanase; Allelock
Company	Alcon
Indication	Allergic conjunctivitis			Approved    [1]
	Ocular allergy			Phase III    [1]
Structure	Click to save drug structure in 3D MOL format Click to save drug structure in 2D MOL format
Therapeutic Class	Antiallergic Agents
CAS Number	CAS 113806-05-6
Formular	C21H23NO3
PubChem Compound ID	CID 5281071.
PubChem Substance ID	SID 698647.
SuperDrug ATC ID	S01GX09;
SuperDrug CAS ID	113806056;
Target	Histamine H1 receptor			Antagonist	[1]
	Histamine H1 receptor			Antagonist	[2]
Ref 1	Emerging drugs for ocular allergy. Expert Opin Emerg Drugs. 2005 Aug;10(3):505-20. To Reference
Ref 2	Pharmacokinetics of orally administered single- and multiple-dose olopatadine in healthy Chinese subjects: an open-label study. Clin Drug Investig. 2009;29(7):451-7. doi: 10.2165/00044011-200929070-00003. To Reference

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.

Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore

All rights reserved.